600161 Beijing Tiantan Biological Products Corporation
- 20.88
- -0.02-0.10%
Beijing Tiantan Biological Products Corporation News
Tiantan Biotech\'s announcement on Chengdu Rongsheng\'s acquisition of 100% of Wuhan Zhongyuan Reide Biological Products Co., Ltd.
Beijing Tiantan Biological Products Corporation's 2023 annual equity distribution implementation announcement.
Tiantan Biotech 2023 Profit Distribution and Capital Stock Transfer Plan Announcement
Announcement of Tiantan Biotech on the completion of the implementation of a plan to promote “improving quality, increasing efficiency and increasing returns” and increase the shareholding of directors, supervisors and senior management
Tiantan Biotech\'s announcement on the progress of some directors, supervisors and senior managers to increase their shareholding
Tiantan Biotech\'s announcement on plans to increase shareholding by directors, supervisors and senior managers
Tiantan Biotech 2022 Annual Equity Distribution Implementation Notice
Tiantan Biotech Simplified Equity Change Report
Prompt announcement by Tiantan Biotech on changes in the controlling shareholders\' equity
China International Finance Corporation\'s 2022 Continued Supervision Report on the Non-public Offering of Shares by Beijing Tiantan Biological Products Co., Ltd.
China International Finance Corporation\'s Summary Report on Continued Supervision and Sponsorship of the Non-public Offering of Shares by Beijing Tiantan Biological Products Co., Ltd.
Tiantan Biotech 2022 Annual Profit Distribution Plan Announcement
Tiantan Biotech 2021 Annual Equity Distribution Implementation Notice
Prompt announcement by Tiantan Biotech on the continuation of the separation of affiliated companies
China International Finance Corporation's 2021 Continued Supervision Report on the Non-public Offering of Shares by Beijing Tiantan Biological Products Co., Ltd.
Tiantan Biotech's 2021 Annual Profit Distribution and Capital Transfer Plan Announcement
Tiantan Biotech: Tiantan Biotech's non-public offering of restricted shares listing and circulation announcement
Tiantan Biotech: Tiantan Biotech 2020 Annual Equity Distribution Implementation Notice
Tiantan Biotech: Tiantan Biotech's announcement that its application for a non-public offering of shares was approved and approved by the China Securities Regulatory Commission
Tiantan Biotech: Tiantan Biotech's announcement that the application for the non-public offering of A-shares was reviewed and approved by the Issuance Review Committee of the China Securities Regulatory Commission
Analysis
Price Target
No Data
No Data